Polycystic ovary syndrome (PCOS) affects ~10% of women of reproductive age and is closely linked to insulin resistance and weight. GLP-1 medications aren't approved for PCOS specifically, but the overlap between PCOS management and GLP-1's mechanisms is significant.

What the research shows.

A meta-analysis of 27 randomized controlled trials found GLP-1 medications improved several key PCOS markers:

Insulin Resistance: Significant improvement in HOMA-IR (a measure of insulin sensitivity). Since insulin resistance drives many PCOS symptoms, this is the mechanism with the broadest impact.

Hormonal Profile: Reduced testosterone levels and improved sex hormone-binding globulin (SHBG), both associated with reduced PCOS symptom severity.

Menstrual Regularity: Some studies reported improved cycle regularity, likely secondary to weight loss and improved insulin sensitivity.

Weight Loss: The primary mechanism. Even 5-10% body weight loss can meaningfully improve PCOS outcomes.

Important caveats.

Not FDA-approved for PCOS. GLP-1 medications are approved for weight management and type 2 diabetes. Any use for PCOS is off-label.

Fertility implications. If you're trying to conceive or may become pregnant, discuss GLP-1 use carefully with your doctor. These medications should be stopped before pregnancy, and improved ovulation from weight loss means you may be more fertile than expected.

Not a replacement for PCOS-specific treatment. Metformin, hormonal contraceptives, and other PCOS treatments address specific symptoms that GLP-1 may not fully cover.

Worth remembering
GLP-1 is off-label for PCOS, and improved ovulation from weight loss can mean unexpected fertility. If you might become pregnant, this is a conversation to have with your doctor before starting.
Read next Myths vs evidence: what's actually true

The community perspective.

Many people with PCOS describe GLP-1 medications as addressing the root cause (insulin resistance and weight) rather than just managing symptoms. For those who struggled with weight loss through conventional means despite doing "everything right," the medication can feel like the first approach that actually accounts for their metabolic reality.

Working with your doctor.

If you have PCOS and are considering or already taking GLP-1 medications:

Sources

  1. REVIEWDual impact of GLP-1 RA on metabolic and reproductive health in PCOS (PMC)
  2. META-ANALYSISGLP-1 RA in PCOS: meta-analysis (Nature)
  3. META-ANALYSISGLP-1 RA in PCOS women with obesity: meta-analysis (ScienceDirect)
  4. JOURNALSuperior metabolic improvement with GLP-1 multi-agonist in PCOS (Nature Communications)
  5. REVIEWGLP-1 RA vs metformin in PCOS: systematic review (RBMO)
  6. CLINICALTRIALSGLP-1 RAs in patients with PCOS (NCT04876027)

This article is for educational purposes only and is not medical advice. GLP-1 is not FDA-approved for PCOS treatment. Always consult your healthcare provider.